0001127602-21-022637.txt : 20210730 0001127602-21-022637.hdr.sgml : 20210730 20210730162047 ACCESSION NUMBER: 0001127602-21-022637 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210729 FILED AS OF DATE: 20210730 DATE AS OF CHANGE: 20210730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gaffin David Joseph CENTRAL INDEX KEY: 0001675905 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 211132830 MAIL ADDRESS: STREET 1: 852 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-772-8000 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN 4 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-07-29 0001520262 Alkermes plc. ALKS 0001675905 Gaffin David Joseph 852 WINTER STREET WALTHAM MA 02451 1 SVP, CLO, Alkermes, Inc. Ordinary Shares 2021-07-29 4 M 0 14000 16.55 A 88597 D Ordinary Shares 2021-07-29 4 S 0 14000 26.00 D 74597 D Employee Stock Option (Right to Buy) 16.55 2021-07-29 4 M 0 14000 0 D 2022-05-21 Ordinary Shares 14000 0 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. These options are fully vested in accordance with their terms. /s/ Shantale Greenson, attorney-in-fact for David J. Gaffin 2021-07-30